Akreditace pro obor Zubní lékařství

Mandarim-de-Lacerda CA: Pathobiology 68, 36, 2000
Šimko F: Physiol Res 49, 37, 2000
Bartunek J: Circulation 101, 423, 2000
Mandarim-de-Lacerda CA: Ann Anat 183,171,2001
Pereira LMM: Anal Quant Cytol 23,330,2001
Litzman J, Ward, Wild, Znojil V, Morgan: Int Arch Allergy Immunol 114, 54, 1997
Sanal O: Int Arch Allergy Immunol 116,246,1998
Levan-Petit I: Clin Chem 46, 876, 2000
Haraldsson A: Scand J Immunol 51, 415, 2000
Vladutiu AO: Clin Diagn Lab Immunol 7, 131, 2000
Preud'homme JL: Mol Immunol 37,871,2000
Pospíšil M, Hofer M, Znojil V, Netíková J, Vácha J, Holá J, Vacek A: Granulocyte
colony-stimulating factor and drugs elevating extracellular adenosine synergize to
enhance haematopoietic reconstruction in irradiated mice. Eur J Haematol 60, 172,
1998
Fedorocko P: Int J Immunopharmacol 22, 989, 2000
Weiterová L, Hofer M: Eur J Haematol 65, 310, 2000
Fishman P: J Cell Physiol 183, 393, 2000
Ohana G: J Cell Physiol 186, 19, 2001
Wen ZY: Clin Hemorheol Micro 25,75,2001
Vašku A, Soucek M, Znojil V, Rihácek M, Cídl K, Strelcová L, Vácha J: Does
angiotensin I-converting enzyme inhibitor therapy have an antiproliferative effect
on blood-forming bone marrow? Exp Hematol 26, 277, 1998
Praloran V: Exp Hematol 26,1020,1998
Boranic M: Exp Hematol 26,1018,1998
Stanovic S: Haematologia 30, 1, 2000
Vašku A, Soucek M, Znojil V, Rihácek I, Tschöplová S, Strelcová L, Cídl K,
Blažková M, Hájek D, Hollá L, Vácha J: Angiotensin I-converting enzyme and
angiotensinogen gene interaction and prediction of essential hypertension. Kidney
International 53, 1479, 1998
Dominiczak AF: Molecular Genetics of Hypertension. Oxford: BIOS Sci Publ Ltd, 1999
Satoh T: Internal Med 38, 919, 1999
Fomicheva EV: Mol Genet Metab 69, 76, 2000
Pospíšilová Y: Vnitr Lek 46, 166, 2000
Gainer JV: Am J Hypertens 13, 1268, 2000
Šerý O: Physiol Res 50,43,2001
Zabay JM: Nefrologia 21,115,2001
Fernandez-Arcas A: Clin Genet 60,52,2001
Pereira AC: Braz J Med Biol Res 34,1421,2001
Kanovský P, Streitová H, Dufek J, Znojil V, Daniel P, Rektor I: Change in
lateralization of the P22/N30 cortical component of median nerve somatosensory
evoked potentials in patients with cercical dystonia after successful treatment with
botulinum toxin A. Movement Disord 13, 108, 1998
Bentivoglio AR: Curr Opin Neurol 12, 447, 1999
Tinazzi M: Movement Disord 14, 473, 1999
Wober C: Eur Neurol 41, 194, 1999
Murase A: Brain 123, 1813, 2000
288